Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 3.15
SIAL's Cash to Debt is ranked higher than
81% of the 1467 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.48 vs. SIAL: 3.15 )
SIAL' s 10-Year Cash to Debt Range
Min: 0.08   Max: 9.98
Current: 3.15

0.08
9.98
Equity to Asset 0.77
SIAL's Equity to Asset is ranked higher than
90% of the 1295 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.48 vs. SIAL: 0.77 )
SIAL' s 10-Year Equity to Asset Range
Min: 0.53   Max: 0.88
Current: 0.77

0.53
0.88
Interest Coverage 170.25
SIAL's Interest Coverage is ranked higher than
72% of the 814 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 21.55 vs. SIAL: 170.25 )
SIAL' s 10-Year Interest Coverage Range
Min: 14.25   Max: 226.55
Current: 170.25

14.25
226.55
F-Score: 6
Z-Score: 14.10
M-Score: -2.64
WACC vs ROIC
3.99%
19.66%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 24.60
SIAL's Operating margin (%) is ranked higher than
97% of the 1459 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.82 vs. SIAL: 24.60 )
SIAL' s 10-Year Operating margin (%) Range
Min: 15.5   Max: 25.83
Current: 24.6

15.5
25.83
Net-margin (%) 18.04
SIAL's Net-margin (%) is ranked higher than
97% of the 1459 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.93 vs. SIAL: 18.04 )
SIAL' s 10-Year Net-margin (%) Range
Min: 10.83   Max: 30.95
Current: 18.04

10.83
30.95
ROE (%) 16.20
SIAL's ROE (%) is ranked higher than
88% of the 1444 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.96 vs. SIAL: 16.20 )
SIAL' s 10-Year ROE (%) Range
Min: 13.92   Max: 30.23
Current: 16.2

13.92
30.23
ROA (%) 12.41
SIAL's ROA (%) is ranked higher than
93% of the 1475 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.71 vs. SIAL: 12.41 )
SIAL' s 10-Year ROA (%) Range
Min: 9.06   Max: 23.04
Current: 12.41

9.06
23.04
ROC (Joel Greenblatt) (%) 40.25
SIAL's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 1468 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 10.62 vs. SIAL: 40.25 )
SIAL' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 18.32   Max: 43.69
Current: 40.25

18.32
43.69
Revenue Growth (3Y)(%) 4.40
SIAL's Revenue Growth (3Y)(%) is ranked higher than
70% of the 1196 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.90 vs. SIAL: 4.40 )
SIAL' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0.4   Max: 16.1
Current: 4.4

0.4
16.1
EBITDA Growth (3Y)(%) 3.50
SIAL's EBITDA Growth (3Y)(%) is ranked higher than
73% of the 1091 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.40 vs. SIAL: 3.50 )
SIAL' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 1.9   Max: 18
Current: 3.5

1.9
18
EPS Growth (3Y)(%) 3.90
SIAL's EPS Growth (3Y)(%) is ranked higher than
73% of the 991 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.40 vs. SIAL: 3.90 )
SIAL' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 19.7
Current: 3.9

0
19.7
» SIAL's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

SIAL Guru Trades in Q2 2014

Tom Gayner 6,000 sh (New)
Jim Simons 398,700 sh (+27.26%)
Jeremy Grantham 286,278 sh (+21.16%)
Joel Greenblatt 39,753 sh (+2.71%)
Manning & Napier Advisors, Inc 106,110 sh (+0.26%)
Donald Yacktman 2,398,185 sh (+0.03%)
First Pacific Advisors 2,700 sh (unchged)
Dodge & Cox 20,500 sh (unchged)
Yacktman Fund 1,096,000 sh (unchged)
Yacktman Focused Fund 944,000 sh (unchged)
Bill Frels 11,064 sh (unchged)
Chris Davis 239,643 sh (-0.64%)
Ken Fisher 72,039 sh (-1.57%)
Murray Stahl 204,792 sh (-6.43%)
» More
Q3 2014

SIAL Guru Trades in Q3 2014

Caxton Associates 7,714 sh (New)
First Eagle Investment 7,500 sh (New)
Louis Moore Bacon 10,000 sh (New)
Mario Gabelli 322,900 sh (New)
Tom Gayner 18,000 sh (+200.00%)
Jim Simons 420,100 sh (+5.37%)
Jeremy Grantham 287,225 sh (+0.33%)
First Pacific Advisors 2,700 sh (unchged)
Manning & Napier Advisors, Inc Sold Out
Ken Fisher 67,789 sh (-5.90%)
Dodge & Cox 19,000 sh (-7.32%)
Murray Stahl 171,898 sh (-16.06%)
Yacktman Fund 846,000 sh (-22.81%)
Donald Yacktman 1,786,911 sh (-25.49%)
Yacktman Focused Fund 694,000 sh (-26.48%)
Joel Greenblatt 28,392 sh (-28.58%)
Bill Frels 6,564 sh (-40.67%)
Chris Davis 136,292 sh (-43.13%)
» More
Q4 2014

SIAL Guru Trades in Q4 2014

Caxton Associates 30,687 sh (+297.81%)
Jeremy Grantham 1,059,591 sh (+268.91%)
First Eagle Investment 12,500 sh (+66.67%)
Jim Simons 631,332 sh (+50.28%)
Mario Gabelli 373,857 sh (+15.78%)
Yacktman Fund 846,000 sh (unchged)
First Pacific Advisors 2,700 sh (unchged)
Dodge & Cox 19,000 sh (unchged)
Tom Gayner Sold Out
Ken Fisher Sold Out
Louis Moore Bacon Sold Out
Bill Frels 6,214 sh (-5.33%)
Donald Yacktman 1,559,598 sh (-12.72%)
Yacktman Focused Fund 471,700 sh (-32.03%)
Murray Stahl 85,549 sh (-50.23%)
Chris Davis 36,659 sh (-73.10%)
Joel Greenblatt 4,527 sh (-84.06%)
» More
Q1 2015

SIAL Guru Trades in Q1 2015

Jim Simons 861,132 sh (+36.40%)
Mario Gabelli 434,150 sh (+16.13%)
First Eagle Investment 12,500 sh (unchged)
First Pacific Advisors 2,700 sh (unchged)
Dodge & Cox 19,000 sh (unchged)
Chris Davis Sold Out
Caxton Associates Sold Out
Yacktman Fund 800,000 sh (-5.44%)
Donald Yacktman 1,428,207 sh (-8.42%)
Bill Frels 5,613 sh (-9.67%)
Yacktman Focused Fund 400,000 sh (-15.20%)
Jeremy Grantham 809,034 sh (-23.65%)
Joel Greenblatt 1,512 sh (-66.60%)
Murray Stahl 24,890 sh (-70.91%)
» More
» Details

Insider Trades

Latest Guru Trades with SIAL

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Sigma-Aldrich Corp

Weekly 52-Week Highs Highlight: SIAL, GIS, TJX, HSP
According to GuruFocus list of 52-week highs, Sigma-Aldrich Corp, General Mills Inc, TJX Companies, and Hospira Inc. have all reached their 52-week highs. Read more...
Searching For Stocks With Solid Dividend Increases
Dividend-paying stocks are vital for income investors. There are several metrics to examine when sorting through the options, one of the most important of which is the company’s history of dividend increases — crucial for long-term investors. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 33.40
SIAL's P/E(ttm) is ranked higher than
66% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 29.90 vs. SIAL: 33.40 )
SIAL' s 10-Year P/E(ttm) Range
Min: 12.12   Max: 33.45
Current: 33.4

12.12
33.45
Forward P/E 29.15
SIAL's Forward P/E is ranked higher than
75% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.00 vs. SIAL: 29.15 )
N/A
PE(NRI) 33.40
SIAL's PE(NRI) is ranked higher than
69% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 30.10 vs. SIAL: 33.40 )
SIAL' s 10-Year PE(NRI) Range
Min: 12.14   Max: 33.43
Current: 33.4

12.14
33.43
P/B 5.25
SIAL's P/B is ranked lower than
53% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.23 vs. SIAL: 5.25 )
SIAL' s 10-Year P/B Range
Min: 2.87   Max: 5.28
Current: 5.25

2.87
5.28
P/S 6.03
SIAL's P/S is ranked lower than
66% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.19 vs. SIAL: 6.03 )
SIAL' s 10-Year P/S Range
Min: 1.92   Max: 6.03
Current: 6.03

1.92
6.03
PFCF 33.19
SIAL's PFCF is ranked higher than
74% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 107.86 vs. SIAL: 33.19 )
SIAL' s 10-Year PFCF Range
Min: 12.57   Max: 33.19
Current: 33.19

12.57
33.19
POCF 26.95
SIAL's POCF is ranked higher than
64% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 16.18 vs. SIAL: 26.95 )
SIAL' s 10-Year POCF Range
Min: 9.67   Max: 26.95
Current: 26.95

9.67
26.95
EV-to-EBIT 23.45
SIAL's EV-to-EBIT is ranked higher than
70% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 23.27 vs. SIAL: 23.45 )
SIAL' s 10-Year EV-to-EBIT Range
Min: 8.8   Max: 23.7
Current: 23.45

8.8
23.7
PEG 4.51
SIAL's PEG is ranked higher than
85% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.00 vs. SIAL: 4.51 )
SIAL' s 10-Year PEG Range
Min: 0.89   Max: 5.27
Current: 4.51

0.89
5.27
Shiller P/E 36.50
SIAL's Shiller P/E is ranked higher than
75% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.00 vs. SIAL: 36.50 )
SIAL' s 10-Year Shiller P/E Range
Min: 15.2   Max: 37.2
Current: 36.5

15.2
37.2
Current Ratio 5.94
SIAL's Current Ratio is ranked higher than
96% of the 1304 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.68 vs. SIAL: 5.94 )
SIAL' s 10-Year Current Ratio Range
Min: 1.54   Max: 7.34
Current: 5.94

1.54
7.34
Quick Ratio 4.00
SIAL's Quick Ratio is ranked higher than
95% of the 1304 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.12 vs. SIAL: 4.00 )
SIAL' s 10-Year Quick Ratio Range
Min: 0.58   Max: 4
Current: 4

0.58
4
Days Inventory 193.18
SIAL's Days Inventory is ranked lower than
54% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 73.25 vs. SIAL: 193.18 )
SIAL' s 10-Year Days Inventory Range
Min: 186.78   Max: 416.32
Current: 193.18

186.78
416.32
Days Sales Outstanding 52.80
SIAL's Days Sales Outstanding is ranked higher than
78% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 70.30 vs. SIAL: 52.80 )
SIAL' s 10-Year Days Sales Outstanding Range
Min: 44.75   Max: 75.61
Current: 52.8

44.75
75.61

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.66
SIAL's Dividend Yield is ranked lower than
77% of the 1158 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.72 vs. SIAL: 0.66 )
SIAL' s 10-Year Dividend Yield Range
Min: 0.66   Max: 1.64
Current: 0.66

0.66
1.64
Dividend Payout 0.22
SIAL's Dividend Payout is ranked higher than
88% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.74 vs. SIAL: 0.22 )
SIAL' s 10-Year Dividend Payout Range
Min: 0.03   Max: 0.26
Current: 0.22

0.03
0.26
Dividend growth (3y) 8.50
SIAL's Dividend growth (3y) is ranked higher than
80% of the 760 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.30 vs. SIAL: 8.50 )
SIAL' s 10-Year Dividend growth (3y) Range
Min: 5.3   Max: 30
Current: 8.5

5.3
30
Yield on cost (5-Year) 1.12
SIAL's Yield on cost (5-Year) is ranked lower than
69% of the 1163 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.97 vs. SIAL: 1.12 )
SIAL' s 10-Year Yield on cost (5-Year) Range
Min: 1.06   Max: 2.63
Current: 1.12

1.06
2.63
Share Buyback Rate 0.80
SIAL's Share Buyback Rate is ranked higher than
90% of the 788 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -0.70 vs. SIAL: 0.80 )
SIAL' s 10-Year Share Buyback Rate Range
Min: 10.1   Max: -0.4
Current: 0.8

Valuation & Return

vs
industry
vs
history
Price/Net Cash 4636.00
SIAL's Price/Net Cash is ranked higher than
94% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.00 vs. SIAL: 4636.00 )
SIAL' s 10-Year Price/Net Cash Range
Min: 357.92   Max: 4608.33
Current: 4636

357.92
4608.33
Price/Net Current Asset Value 13.27
SIAL's Price/Net Current Asset Value is ranked higher than
92% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.00 vs. SIAL: 13.27 )
SIAL' s 10-Year Price/Net Current Asset Value Range
Min: 4.85   Max: 188.41
Current: 13.27

4.85
188.41
Price/Tangible Book 7.77
SIAL's Price/Tangible Book is ranked lower than
56% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.00 vs. SIAL: 7.77 )
SIAL' s 10-Year Price/Tangible Book Range
Min: 2.6   Max: 7.84
Current: 7.77

2.6
7.84
Price/DCF (Projected) 2.23
SIAL's Price/DCF (Projected) is ranked higher than
78% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.00 vs. SIAL: 2.23 )
SIAL' s 10-Year Price/DCF (Projected) Range
Min: 0.9   Max: 2.94
Current: 2.23

0.9
2.94
Price/Median PS Value 1.88
SIAL's Price/Median PS Value is ranked higher than
50% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.40 vs. SIAL: 1.88 )
SIAL' s 10-Year Price/Median PS Value Range
Min: 0.7   Max: 1.87
Current: 1.88

0.7
1.87
Price/Peter Lynch Fair Value 5.27
SIAL's Price/Peter Lynch Fair Value is ranked higher than
90% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.00 vs. SIAL: 5.27 )
SIAL' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.03   Max: 5.24
Current: 5.27

1.03
5.24
Price/Graham Number 3.39
SIAL's Price/Graham Number is ranked higher than
64% of the 1616 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.90 vs. SIAL: 3.39 )
SIAL' s 10-Year Price/Graham Number Range
Min: 1.38   Max: 3.38
Current: 3.39

1.38
3.38
Earnings Yield (Greenblatt) 4.30
SIAL's Earnings Yield (Greenblatt) is ranked higher than
65% of the 1453 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.90 vs. SIAL: 4.30 )
SIAL' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.2   Max: 11.3
Current: 4.3

4.2
11.3
Forward Rate of Return (Yacktman) 9.09
SIAL's Forward Rate of Return (Yacktman) is ranked higher than
81% of the 834 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.68 vs. SIAL: 9.09 )
SIAL' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 9.1   Max: 19.9
Current: 9.09

9.1
19.9

Business Description

Industry: Chemicals » Specialty Chemicals
Compare:NEU, SCL, VAL, POL, CYT » details
Traded in other countries:SIQ.Germany,
Sigma-Aldrich Corp was incorporated under the laws of the State of Delaware in May 1975. The Company is a life science and a technology company that helps in enhancing human health and safety. The Company manufactures and distributes chemicals, biochemicals and other essential products and equipment products to its customers in research and applied labs as well as in industrial and commercial markets. The Company operates in three units including Research, Applied and SAFC Commercial. The Research unit products and services includes chemicals, reagents and kits, enabling the scientists to discover and develop new drugs and materials; Applied unit products and services includes high quality components and kits, chemical reagents, critical raw materials and certified reference standards, providing customized solutions to and constitute critical components and materials for diagnostic companies, testing laboratories and industrial companies; SAFC Commercial unit's products and services are used by its customers to develop and manufacture pharma, biopharma and electronics products. Its customers include pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies and hospitals. The Company's trademarks are the brand names; Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de Haën, Supelco, SAFC, SAFC Biosciences, SAFC Hitech, Genosys, Proligo, Pharmorphix, Cerilliant, Vetec, BioReliance and Cell Marque. The Company is subject to extensive regulation by federal, state and local governments and similar international agencies relating to the manufacture, sale and distribution of its products.
» More Articles for SIAL

Headlines

Articles On GuruFocus.com
Weekly 52-Week Highs Highlight: SIAL, GIS, TJX, HSP Mar 30 2015 
Searching For Stocks With Solid Dividend Increases Jan 27 2015 
World Economic Forum 2015 – What To Look Forward For Jan 18 2015 
Weekly 52-Week Highs Highlight: HCP, SIAL, SBUX, KR Dec 14 2014 
Dividend Aristocrats In Focus Parts 30: Sigma-Aldrich Oct 28 2014 
Reasons Why I Will Bet on Sigma Sep 26 2014 
Top Three Holdings with Promising Outlook Jul 15 2014 
High Trade Volume, and Gurus’ 2013 Preferred Stock Apr 21 2014 
Weekly 52-Week Highs Highlight: MGM, SIAL, ADBE, LVS Dec 16 2013 
Weekly Top Insider Buys: Apache Corporation, Sigma-Aldrich Corporation, Huntington Bancshares, Ameri Sep 09 2013 

More From Other Websites
Germany's Merck expects drug division to drive growth-Euro am Sonntag May 23 2015
Merck KGaA profits decline on Sigma-Aldrich acquisition costs May 19 2015
Merck Profit Pressured by M&A Financing May 19 2015
Merck KGaA says to overcome EU concerns on Sigma-Aldrich deal May 19 2015
SIGMA ALDRICH CORP Financials May 13 2015
Sigma-Aldrich's SAFC Completes St. Louis Facility Expansion - Analyst Blog May 13 2015
SAFC Completes ADC Commercial Manufacturing Capacity Expansion in St. Louis May 12 2015
SAFC Expands Carlsbad, Calif. Facility to Support Commercial-Scale Gene Therapy Production, Testing... May 12 2015
SAFC Expands Carlsbad, Calif. Facility to Support Commercial-Scale Gene Therapy Production, Testing... May 12 2015
SAFC Completes ADC Commercial Manufacturing Capacity Expansion in St. Louis May 12 2015
Sigma-Aldrich Q1 Earnings and Revenues Miss Estimates - Analyst Blog May 07 2015
SIGMA ALDRICH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 07 2015
Sigma-Aldrich (SIAL) Misses Q1 Earnings and Revenue Estimates - Tale of the Tape May 07 2015
Sigma-Aldrich misses Street 1Q forecasts May 07 2015
Sigma-Aldrich misses Street 1Q forecasts May 07 2015
Q1 2015 Sigma-Aldrich Corp Earnings Release - Before Market Open May 07 2015
Sigma-Aldrich (NASDAQ - SIAL) Reports Q1 2015 Sales Of $676 Million And Adjusted Diluted EPS Of... May 07 2015
Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research... May 06 2015
SIGMA ALDRICH CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 05 2015
Annual Report & Accounts 2014 and Notice of Meeting Apr 29 2015
Energizer announces new board members for upcoming split Apr 27 2015
Will Sigma-Aldrich (SIAL) Miss Earnings Estimates in Q1? - Analyst Blog Apr 21 2015
St. Louis companies among the 'best corporate citizens' Apr 21 2015
BioReliance Licenses B-CLEAR® Technology from Qualyst Transporter Solutions for Drug Transporter... Apr 21 2015
BioReliance Licenses B-CLEAR® Technology from Qualyst Transporter Solutions for Drug Transporter... Apr 21 2015
Sigma-Aldrich Named to CR Magazine's 100 Best Corporate Citizens List Apr 20 2015
Sigma-Aldrich Named to CR Magazine's 100 Best Corporate Citizens List Apr 20 2015
Merck aims to quickly repay up to $5 bln in loans - CFO in Boersen-Zeitung Apr 18 2015
Merck aims to quickly repay up to $5 bln in loans -CFO in Boersen-Zeitung Apr 18 2015
Sigma-Aldrich (SIAL) Opens New Cell Culture Technical Center - Analyst Blog Apr 17 2015
Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class... Apr 17 2015
Walker signs deal with German researchers, meets with Merck Apr 13 2015
SAFC Launches New EX-CELL® Advanced™ Products for Scalable, Efficient Biopharmaceutical... Apr 07 2015
DIRECTORS/PDMR SHAREHOLDING Mar 31 2015
DIRECTORS/PDMR SHAREHOLDING Mar 31 2015
PDMR SHAREHOLDING Mar 31 2015
DIRECTORS/PDMR SHAREHOLDING Mar 31 2015
DIRECTORS/PDMR SHAREHOLDING Mar 31 2015
Sigma-Aldrich® Global Green Chemistry Initiative: Next Phase Kicked-off with Special Issue of... Mar 20 2015
Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche Mar 19 2015
Preliminary Results for the Year Ending 31 December 2014 Mar 12 2015
China's BeiGene Selects SAFC CHOZN® Platform for Commercial Drug Development Mar 11 2015
Notice of Results Mar 05 2015
Cerilliant Introduces Certified Spiking Solutions® of Tryptamines Feb 24 2015
Sigma® Life Science Releases Next-Gen Sequencing Oligos Feb 18 2015
Sigma-Aldrich tops Street 4Q forecasts Feb 12 2015
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Full-Year 2014 Sales Of $2.79 Billion And Record... Feb 12 2015
Sigma-Aldrich meets 3Q profit forecasts Oct 23 2014
Banks line up $15.6 billion loan for Merck's Sigma-Aldrich buy Sep 23 2014
Germany's Merck to buy Sigma-Aldrich for $17 billion to boost lab supplies operation Sep 22 2014
US STOCKS-Wall St dips after China economic policy comments Sep 22 2014
Merck still sees investment grade ratings after Sigma-Aldrich deal Sep 22 2014
German Merck to buy St. Louis-based Sigma-Aldrich Sep 22 2014
Merck to buy US Sigma-Aldrich for 13.1 bn euros Sep 22 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK